Clinical Drug Experience Knowledgebase

Amyotrophic Lateral Sclerosis (Phase 1)

Arterial Occlusive Diseases (Phase 2)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 3)

Atrophy (Phase 4)

Blood Platelet Disorders (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Cerebral Hemorrhage (Phase 3)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 4)

Cross Infection (Phase 4)

Cystitis, Interstitial (Phase 4)

Digestive System Neoplasms (Phase 2)

Embolism (Phase 3)

Endocrine Gland Neoplasms (Phase 2)

Gastrointestinal Neoplasms (Phase 2)

Hemorrhage (Phase 3)

Hypercholesterolemia (Phase 4)

Hypertension (Phase 4)

Infections (Phase 4)

Inflammation (Phase 4)

Influenza, Human (Phase 4)

Intermittent Claudication (Phase 2)

Intracranial Hemorrhages (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Neoplasms (Phase 3)

Metabolic Syndrome (Phase 4)

Motor Neuron Disease (Phase 1)

Multiple Endocrine Neoplasia (Phase 2)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 3)

Multiple System Atrophy (Phase 4)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 3)

Nausea (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neuroendocrine Tumors (Phase 2)

Pain (Phase 4)

Pancreatic Neoplasms (Phase 2)

Parkinson Disease (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Pulmonary Embolism (Phase 3)

Respiratory Tract Neoplasms (Phase 2)

Sclerosis (Phase 3)

Shy-Drager Syndrome (Phase 4)

Stroke (Phase 3)

Syndrome (Phase 4)

Thrombocytopenia (Phase 2)

Thromboembolism (Phase 3)

Thrombosis (Phase 3)

Thymus Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 3)

Urinary Bladder, Overactive (Phase 3)

Urinary Tract Infections (Phase 2)

Venous Thromboembolism (Phase 3)

Venous Thrombosis (Phase 3)

Ventricular Dysfunction (Phase 2)

Vomiting (Phase 3)